Announcement 05

Development of Annual General Meeting

The Annual General Meeting was held in accordance with the published agenda (announcement dated March 12, 2008).

The General Meeting took note of the report on the Company’s activities and adopted the Annual Report 2007. Also, the General Meeting adopted the proposed decision on use of profit/loss as well as remuneration for the Board of Directors.

All proposals from the Board of Directors in the agenda’s item 3 were carried unanimously, thus:

a.Merging of class A and class B shares into a single class with class B as the continued class;

b.The formulation of article 8 of the Company Articles on exercising the right to vote is made more explicit to ensure that double voting cannot occur;

c.Guidelines for the incentive-based remuneration of the Board of Directors and Executive Management, for insertion into article 16 of the Company Articles, were approved;

d.The Board of Directors is authorized to issue, on one or more occasions, a number of warrants for shares of nominal value DKK 3.00 corresponding to a maximum of 5% of the Company’s nominal share capital at any given time;

e.The Board of Directors is authorized to repurchase the Company’s own shares up to 10% of the share capital at any time;

f.
Additional minor amendments to the Company Articles are made;

All board members were up for election. All members were re-elected, i.e. Carsten Lønfeldt, Ejner Bech Jensen, Peter Nordkild and Niels T. Foged. After the meeting the Board constituted itself with Carsten Lønfeldt as chairman.

Deloitte was re-elected auitor for BioPorto A/S

Gentofte, March 28, 2008

The Board of Directors

For further information please contact:

Thea Olesen, CEO

Tel. +45 45 29 00 00, e-mail to@bioporto.com